A study has found that patients with ischemic stroke and COVID-19, compared with patients without COVID-19, experience worse recovery outcomes.

Higher calcium intake is associated with reduced colorectal cancer risk across tumor sites and calcium sources.

The Food and Drug Administration (FDA) has granted Fast Track designation to BRTX-100 for the treatment of chronic lumbar disc disease, defined as back and/or radicular pain with confirmed ...

Pegloticase therapy for uncontrolled gout does not appear to significantly increase the risk for cardiovascular (CV) or thromboembolic (TE) events, despite the potential for increased gout flares ...

Selarsdi (ustekinumab-aekn; Teva and Alvotech), and Yesintek (ustekinumab-kfce; Biocon Biologics), all biosimilars to Stelara (ustekinumab; Johnson & Johnson) are now available in the US.

Postpandemic hospital occupancy higher than prepandemic and expected to continue increasing without changes in staffed hospital bed supply.

The use of menopausal hormone therapy is associated with an increased risk of developing SLE and SSc among women.

There is evidence for epidural steroid injections reducing pain and disability in cervical and lumbar radiculopathies.

Frailty is increasingly being viewed as an emerging risk factor for poor outcomes among patients with autoimmune or rheumatic ...

The FDA has approved the BLA for Ospomyv™ and Xbryk™, biosimilars to Prolia (denosumab) and Xgeva (denosumab), respectively.

Given the substantial variability in clinical AI algorithms, implementing effective monitoring solutions is highly recommended.

Tofacitinib and TNF inhibitors demonstrated similar efficacy for managing RA at 12 months, with minor differences noted across tofacitinib treatment lines.